Literature DB >> 16920916

Humoral immune response to flagellin requires T cells and activation of innate immunity.

Catherine J Sanders1, Yimin Yu, Daniel A Moore, Ifor R Williams, Andrew T Gewirtz.   

Abstract

Bacterial flagellin, the primary structural component of flagella, is a dominant target of humoral immunity upon infection by enteric pathogens and in Crohn's disease. To better understand how such responses may be regulated, we sought to define, in mice, basic mechanisms that regulate generation of flagellin-specific Igs. We observed that, in response to i.p. injection with flagellin, generation of flagellin-specific Ig required activation of innate immunity in that these responses were ablated in MyD88-deficient mice and that flagellin from Helicobacter pylori, which is known not to activate TLR5, also did not elicit Abs. Mice lacking alphabeta T cells (TCRbeta(null)) were completely deficient in their ability to make flagellin Abs in various contexts indicating that, in contrast to common belief, generation of flagellin-specific Ig is absolutely T cell dependent. In contrast to Ab responses to whole flagella (H serotyping), responses to flagellin monomers displayed only moderate serospecificity. Whereas neither oral nor rectal administration of flagellin elicited a strong serum Ab response, induction of colitis with dextran sodium sulfate resulted in a MyD88-dependent serum Ab response to endogenous flagellin, suggesting that, in an inflammatory milieu, TLR signaling promotes acquisition of Abs to intestinal flagellin. Thus, acquisition of a humoral immune response to flagellin requires activation of innate immunity, is T cell dependent, and can originate from flagellin in the intestinal tract in inflammatory conditions in the intestine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920916     DOI: 10.4049/jimmunol.177.5.2810

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

Review 1.  Toll like receptor-5: protecting the gut from enteric microbes.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Andrew T Gewirtz
Journal:  Semin Immunopathol       Date:  2007-12-07       Impact factor: 9.623

Review 2.  Inflammatory bowel disease, past, present and future: lessons from animal models.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

Review 3.  Flagellin as an adjuvant: cellular mechanisms and potential.

Authors:  Steven B Mizel; John T Bates
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

4.  Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.

Authors:  Eun-Ju Ko; Youri Lee; Young-Tae Lee; Yu-Jin Jung; Vu L Ngo; Min-Chul Kim; Ki-Hye Kim; Bao-Zhong Wang; Andrew T Gewirtz; Sang-Moo Kang
Journal:  Vaccine       Date:  2019-05-14       Impact factor: 3.641

5.  Lysozyme promotes the release of Toll-like receptor-2 stimulants from gram-positive but not gram-negative intestinal bacteria.

Authors:  Clett Erridge
Journal:  Gut Microbes       Date:  2010 Nov-Dec

6.  Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria.

Authors:  Rawleigh Howe; Stephanie Dillon; Lisa Rogers; Martin McCarter; Caleb Kelly; Ricardo Gonzalez; Nancy Madinger; Cara C Wilson
Journal:  Clin Immunol       Date:  2009-01-25       Impact factor: 3.969

7.  Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin.

Authors:  Wei Li; Jingyi Yang; Ejuan Zhang; Maohua Zhong; Yang Xiao; Jie Yu; Dihan Zhou; Yuan Cao; Yi Yang; Yaoming Li; Huimin Yan
Journal:  Cell Mol Immunol       Date:  2015-04-27       Impact factor: 11.530

Review 8.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

9.  Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease.

Authors:  Chong Shen; Carol J Landers; Carrie Derkowski; Charles O Elson; Stephan R Targan
Journal:  Inflamm Bowel Dis       Date:  2008-12       Impact factor: 5.325

10.  The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5.

Authors:  Clett Erridge; Sylvia H Duncan; Stefan Bereswill; Markus M Heimesaat
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.